title: Anti-bacterial activity of Achatina CRP and its mechanism of action.
abstract: The physiological role of C-reactive protein (CRP), the classical acute-phase protein, is not well documented, despite many reports on biological effects of CRP in vitro and in model systems in vivo. It has been suggested that CRP protects mice against lethal toxicity of bacterial infections by implementing immunological responses. In Achatina fulica CRP is a constitutive multifunctional protein in haemolymph and considered responsible for their survival in the environment for millions of years. The efficacy of Achatina CRP (ACRP) was tested against both Salmonella typhimurium and Bacillus subtilis infections in mice where endogenous CRP level is negligible even after inflammatory stimulus. Further, growth curves of the bacteria revealed that ACRP (50 microg/mL) is bacteriostatic against gram negative salmonellae and bactericidal against gram positive bacilli. ACRP induced energy crises in bacterial cells, inhibited key carbohydrate metabolic enzymes such as phosphofructokinase in glycolysis, isocitrate dehydrogenase in TCA cycle, isocitrate lyase in glyoxylate cycle and fructose-1,6-bisphosphatase in gluconeogenesis. ACRP disturbed the homeostasis of cellular redox potential as well as reduced glutathione status, which is accompanied by an enhanced rate of lipid peroxidation. Annexin V-Cy3/CFDA dual staining clearly showed ACRP induced apoptosis-like death in bacterial cell population. Moreover, immunoblot analyses also indicated apoptosis-like death in ACRP treated bacterial cells, where activation of poly (ADP-ribose) polymerase-1 (PARP) and caspase-3 was noteworthy. It is concluded that metabolic impairment by ACRP in bacterial cells is primarily due to generation of reactive oxygen species and ACRP induced anti-bacterial effect is mediated by metabolic impairment leading to apoptosis-like death in bacterial cells.
authors: Sandip
authors: S
authors: Mukherjee
authors: Soma
authors: S
authors: Barman
authors: Narayan Chandra
authors: NC
authors: Mandal
authors: Shelley
authors: S
authors: Bhattacharya
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D001412:Bacillus subtilis / Q000187:drug effects* / Q000378:metabolism; D002097:C-Reactive Protein / Q000302:isolation & purification / Q000494:pharmacology*; D005943:Gluconeogenesis / Q000187:drug effects; D006019:Glycolysis / Q000187:drug effects; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000378:metabolism / Q000382:microbiology; D006458:Hemolymph / Q000378:metabolism; D006706:Homeostasis / Q000187:drug effects; D015151:Immunoblotting; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D051379:Mice; D010084:Oxidation-Reduction; D017382:Reactive Oxygen Species / Q000378:metabolism; D012480:Salmonella Infections / Q000188:drug therapy* / Q000378:metabolism / Q000382:microbiology; D012486:Salmonella typhimurium / Q000187:drug effects* / Q000378:metabolism; D012908:Snails
chemical_list: D000900:Anti-Bacterial Agents; D017382:Reactive Oxygen Species; D002097:C-Reactive Protein